Cytosorbents Corp CTSO

Healthcare Medical Devices

CytoSorbents Corporation is engaged in the treatment of life-threatening conditions in intensive care (ICU) and cardiac surgery using blood purification via its proprietary polymer adsorption technology. The Company’s flagship product, CytoSorb, is an extracorporeal cytokine absorber, designed to reduce the cytokine storm or cytokine release syndrome that could otherwise cause massive inflammation, organ failure and death in common critical illnesses, such as sepsis, burn injury, trauma, lung injury, cytokine release syndrome due to cancer immunotherapy, and pancreatitis. Its other products include CytoSorb, animal-targeted VetResQ, DrugSorb-ATR and ECOS-300CY. Its other product candidates under development, including CytoSorb XL, BetaSorb, ContrastSorb, DrugSorb, HemoDefend-RBC, HemoDefend-BGA, K+ontrol, and others consist of a cartridge containing adsorbent, porous polymer beads, although the polymers used in these devices are physically different.

NDAQ:CTSO - Post by User

Cytosorbents Corp > great future

<< Previous

Bullboard Posts

Next >>

Post by robertwfbon Sep 02, 2018 1:28pm

264 Views

Post# 28554469

great future

no activety on this board but if any one happens to read this it is not to late to invest in CTSO. Great things are about to happen. do a little DD and get in before it takes off any more than it has already.

<< Previous

Bullboard Posts

Next >>

Maximizing savings: Exploring 5 cash-back and promo deal apps